Yoko Shimada

Identification of Genes Upregulated in <i>ALK</i> -Positive and <i>EGFR/KRAS/ALK</i> -Negative Lung Adenocarcinomas

Hirokazu Okayama, Takashi Kohno, Yuko Ishii et al. · Cancer Research · 2011 · 881 citations · Full text

Medicine, Molecular Biology, Oncology +17

KIF5B-RET fusions in lung adenocarcinoma

Takashi Kohno, Hitoshi Ichikawa, Yasushi Totoki et al. · Nature Medicine · 2012 · 834 citations

Medicine, Molecular Biology, Oncology +14

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

Yoshio Tsujita, Masao Kuroda, Yoko Shimada et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1986 · 375 citations

Life Sciences, Biochemistry, Pharmacology +14

A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1

Takahiro Oike, Hideaki Ogiwara, Yuichi Tominaga et al. · Cancer Research · 2013 · 302 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa et al. · Clinical Cancer Research · 2014 · 218 citations

Medicine, Genetics, Oncology +17